| 5489697 |
Method for the preparation of (+)- Calanolide A and intermediates
thereof |
Method |
Anti-HIV agent |
Phase I/II |
Issued 2/6/96 |
| 6043271 |
Method for the preparation of (+)- Calanolide A and intermediates
thereof |
Method |
Anti-HIV agent |
Phase I/II |
Issued 3/28/00 |
| 5874591 |
Method for the preparation of (+)- Calanolide A and intermediates
thereof |
Method |
Anti-HIV agent |
Phase I/II |
Issued 2/23/99 |
| 5869324 |
Method for the preparation of (+)- Calanolide A and intermediates
thereof |
Method |
Anti-HIV agent |
Phase I/II |
Issued 2/9/99 |
| 5981770 |
Method for the preparation of (+)- Calanolide A and analogues
thereof |
Method |
Anti-HIV agent |
Phase I/II |
Issued 11/9/99 |
| 5977385 |
Method for the preparation of (+)- Calanolide A and analogues
thereof |
Method |
Anti-HIV agent |
Phase I/II |
Issued 11/2/99 |
| 5892060 |
Method for the preparation of (+) -Calanolide A and analogues
thereof |
Method |
Anti-HIV agent |
Phase I/II |
Issued 4/6/99 |
| 5872264 |
Method for the preparation of (+)- Calanolide A and analogues
thereof |
Method |
Anti-HIV agent |
Phase I/II |
Issued 2/16/99 |
| 5859050 |
Method for the preparation of (+)- Calanolide A and analogues
thereof |
Product |
Anti-HIV agent |
Phase I/II |
Issued 1/12/99 |
| 5504111 |
Use of 2,3 alkycarbonyloxybenozic acid in treating adult
respiratory distress syndrome |
Product |
Anti-inflammatory |
Preclinical |
Issued 4/2/96 |
| 6175816 |
Use of automated technology in chemical process R&D; |
Process |
Drug Devel. Optimizer |
N/A |
Issued 1/16/01 |
| 6044212 |
Use of automated technology in chemical process R&D; |
Process |
Drug Devel. |
N/A |
Issued 3/28/00 |
| 5948918 |
Biflavonoids and derivatives thereof as antiviral agents |
Use |
Anti-viral |
N/A |
Issued 9/7/99 |
| 5773462 |
Biflavonoids and derivatives thereof as antiviral agents |
Use |
Anti-viral |
N/A |
Issued 6/30/98 |
| 5874577 |
Method for preparing 9-12-(Diethoxyphosphonomethoxy)ethyl
adenine and analogues thereof |
Method and product |
Anti-viral |
N/A |
Issued 2/23/99 |
| 6160131 |
Scalable method for the isolation of anti-HIV agents from
tropical plant calophyllum |
Method and product |
Anti-HIV agent |
Phase I/II |
Issued 12/12/00 |
| 5847164 |
Method for the preparation of chromanone 7 |
Method and product |
Anti-HIV agent |
Phase I/II |
Issued 2/12/98 |
| 5840921 |
Method for the preparation of aldol product 7B |
Method and product |
Anti-HIV agent |
Phase I/II |
Issued 12/8/98 |
| 6277879 |
Method for the preparation of (+)- Calanolide A and analogues
Thereof |
Method and product |
Anti Viral agents |
|
Issued 8/21/01 |
| 6268393 |
Method and composition for treating and preventing Mycobacterium
Infections |
Method and product |
Anti TB |
Pre clinical |
Issued 7/31/01 |
730178
Australia |
Method for the Preparation of (+)-Calanolide A and intermediates
thereof |
Method and product |
Anti viral agents |
|
Issued 6/14/01 |
704247
Australia |
Method for the preparation of (+)- Calanolide A and intermediates
Thereof |
Method and product |
Anti viral agents |
|
Issued 7/22/99 |
3043813
Japan |
Method for the Preparation of (+)-Calanolide A and intermediates
thereof |
Method and product |
Anti viral agents |
|
Issued 5/22/00 |
37047
Singapore |
Method for the Preparation of (+)-Calanolide A and intermediates
thereof |
Method and product |
Anti viral agents |
|
Issued 9/28/98 |
707798
Australia
|
Biflavanoids and Derivatives thereof as Anti viral agents |
Method and product |
Anti viral agents |
|
Issued 11/4/99 |
| 6225481 |
Robustaflavone, intermediates and Analogues and Method for
Preparation Thereof |
Method and Product |
Anti viral agents |
Discovery |
Issued 5/01/01 |
| 6399654 |
Biflavanoids and derivatives thereof as antiviral agents |
Methods and use |
Antiviral agents |
Discovery |
Issued6/4/2002 |
